Medicinova Inc

General ticker "MNOV" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $106.8M

Medicinova Inc follows the US Stock Market performance with the rate: 32.2%.

Estimated limits based on current volatility of 1.8%: low 2.10$, high 2.18$

Factors to consider:

  • Price in estimated range
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [1.22$, 2.50$]
  • 2024-12-30 to 2025-12-30 estimated range: [1.44$, 2.82$]

Financial Metrics affecting the MNOV estimates:

  • Negative: Non-GAAP EPS, $ of -0.17 <= 0.10
  • Negative: Operating profit margin, % of -90.83 <= 1.03
  • Negative: Operating cash flow per share per price, % of -8.42 <= 2.35
  • Negative: negative Net income
  • Positive: Inventory ratio change, % of 0 <= 0
  • Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
  • Negative: Industry operating profit margin (median), % of -98.30 <= 2.14

Similar symbols

Short-term MNOV quotes

Long-term MNOV plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $4.04MM $0.00MM $1.00MM
Operating Expenses $14.25MM $14.63MM $10.90MM
Operating Income $-10.22MM $-14.63MM $-9.90MM
Non-Operating Income $0.08MM $0.56MM $1.33MM
R&D Expense $8.54MM $9.14MM $5.66MM
Income(Loss) $-10.13MM $-14.07MM $-8.57MM
Taxes $0.00MM $0.00MM $0.00MM
Profit(Loss) $-10.13MM $-14.07MM $-8.57MM
Stockholders Equity $83.68MM $70.24MM $62.38MM
Assets $87.41MM $74.15MM $66.27MM
Operating Cash Flow $-9.38MM $-12.91MM $-7.43MM
Capital expenditure $0.03MM $0.01MM $0.02MM
Investing Cash Flow $-0.03MM $-40.01MM $39.91MM
Financing Cash Flow $20.78MM $0.01MM $0.00MM
Earnings Per Share* $-0.21 $-0.29 $-0.17

* EPS are Split Adjusted, recent splits may be reflected with a delay.